- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Noxopharm Ltd.
Industry Sector: HealthTechnology
CEO: Gisela Mautner, MD, PhD
Number Of Employees: N/A
Enterprise Value: $11,317,058
PE Ratio: -9.75
Exchange/Ticker 1: ASX:NOX
Exchange/Ticker 2: N/A
Latest Market Cap: $14,366,808
BioCentury | Sep 27, 2023
Discovery & Translation
Targeting ACSS2 in solid tumors; plus a multi-lab preclinical trial and more
BioCentury’s roundup of translational innovation
BioCentury | Jun 2, 2018
Product Development
Breaking from the herd
New advances in PD-1 combinations, sarcoma treatments and nucleotides at ASCO
Items per page:
1 - 3 of 3